Internal Medicine, Hematology & Oncology · Shreveport, LA
NPI
1992358352
Since 2019
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1501 Kings Hwy
Shreveport, LA, 71103
Phone (318) 626-0434
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$485K
190 prescriptions
Company payments, 2025
$830
From 20 companies
Medicare prescription drug claims, 2024
In 2024, the drug Rimsha Shaukat prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 18 prescriptions and refills. In total Rimsha Shaukat wrote 190 Medicare prescriptions that cost $485K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-27.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 18 | 18 | 11 | $376 |
| Anastrozole Generic | 17 | 43 | Under 11 | $306 |
| Morphine Sulfate Er Morphine Sulfate | 12 | 12 | Under 11 | $331 |
| Pyrukynd Mitapivat Sulfate | 11 | 11 | Under 11 | $281K |
Brand drugs: 38 claims; generic drugs: 152 claims; opioid claims: 54.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Rimsha Shaukat $830 ($830 in general payments such as food, travel and fees) from 20 companies. The largest payer was Novartis Pharmaceuticals Corporation with $120.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 6 | $120 |
| Daiichi Sankyo Inc. 4568.T | 3 | $117 |
| Pfizer Inc. PFE | 4 | $76.77 |
| GlaxoSmithKline, LLC. GSK | 4 | $74.33 |
| Janssen Biotech, Inc. JNJ | 3 | $66.54 |
| Exelixis Inc. EXEL | 2 | $47.8 |
| Recordati_rare_diseases_inc. | 2 | $41.36 |
| Merck Sharp & Dohme LLC MRK | 2 | $33.7 |
| Gilead Sciences, Inc. GILD | 1 | $31.57 |
| Celgene Corporation BMY | 2 | $29.68 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.